Dynamic Splinting After Total Knee Arthroplasty
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00857701|
Recruitment Status : Terminated (Unrelated to trial)
First Posted : March 9, 2009
Last Update Posted : August 12, 2013
|Condition or disease||Intervention/treatment|
|Reduced Knee Flexion||Device: Knee Extension Dynasplint|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||25 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Dynamic Splinting After Total Knee Arthroplasty: a Randomized, Controlled Trial|
|Study Start Date :||January 2009|
|Estimated Primary Completion Date :||May 2015|
No Intervention: 1
Patient will receive post-surgical standard of care treatment with standard Physical therapy and NSAIDs.
Patients will be treated with the Standard of Care physical therapy and NSAIDs as well as a Knee Extension Dynasplint that includes tension chambers.
Device: Knee Extension Dynasplint
Dynamic Splinting utilizes the protocols of Low-Load, Prolonged-Duration Stretch (LLPS) with calibrated, adjustable tension to increase the Total End Range Time (TERT) to reduce contracture. The Knee Extension Dynasplint for the Experimental group will have tension chambers delivering therapeutic treatment from the device.
- Change in Maximal Acitive Range of Mothion in knee extension [ Time Frame: 9 weeks ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00857701
|United States, Arizona|
|Dennis L Armstrong M.D.|
|Mesa, Arizona, United States, 85206|